Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Mr Stuart Winter, Honorary Senior Clinical Lecturer and Honorary Clinical Research Associate at NDS, along with Professor Hisham Mehanna from the University of Birmingham, have been awarded a Developmental Pathway Funding Scheme (DPFS) grant from the MRC for their project 'Validating the PredicTR treatment response classifier for oropharyngeal cancer (PredicTR 2)'.

Mrc development pathway funding scheme grant awarded

This is a £650K award that will allow the team to build on previous work which identified a potential biomarker for decision making in treating oropharyngeal tumors (tonsil and tongue base) and will fund additional work to develop that predictive model.

The DPFS is a key part of MRC’s Translational Research Strategy and supports the translation of fundamental discoveries toward benefits to human health. It funds the pre-clinical development and early clinical testing of novel therapeutics, devices and diagnostics, including 'repurposing' of existing therapies.